Oncology: FDA grants accelerated approval to zanubrutinib for mantle cell lymphoma

https://www.fda.gov/news-events/press-announcements/fda-approves-therapy-treat-patients-relapsed-and-refractory-mantle-cell-lymphoma-supported-clinical